[Merits and demerits of long acting formulation of cardiovascular drugs].
Nakashima
M
M
Department of Pharmacology, Hamamatsu University School of Medicine.
Hashimoto
H
H
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000368:Aged; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D003692:Delayed-Action Preparations; D006801:Humans; D008875:Middle Aged
D002317:Cardiovascular Agents; D003692:Delayed-Action Preparations